The present invention relates to a method for a non-specific amplification of a natural short-fragment nucleic acid, comprising the following steps: (1) performing end repair on the natural short-fragment nucleic acid to obtain an end-repaired nucleic acid; (2) connecting the end-repaired nucleic acid to a double-stranded linker to obtain a ligation product, in which each strand of the double-stranded linker contains only three bases; (3) performing PCR amplification on the ligation product using a PCR primer labeled with deoxyuridine to obtain a PCR product, in which the PCR primer is completely or partially complementary to a strand of the double-stranded linker and contains only three bases; and (4) digesting the PCR product by using an enzyme having a deoxyuridine cleavage function, followed by digesting the PCR product by using an enzyme with both 5′.fwdarw.3′ polymerase activity and 3′.fwdarw.5′ exonuclease activity in the presence of a deoxynucleotide solution to obtain a non-specific amplification product of the natural short-fragment nucleic acid. The deoxynucleotide solution only contains the complementary base of the base lacking in the primer. The present invention also relates to a kit for implementing the aforementioned method.

Disclosed is a hybridisation capture method based on the pyrophosphorolysis reaction. According to the present invention, there is provided a method for increasing the ratio of a first nucleic acid sequence to second nucleic acid sequence in a sample.

Disclosed is a hybridisation capture method based on the pyrophosphorolysis reaction. According to the present invention, there is provided a method for increasing the ratio of a first nucleic acid sequence to second nucleic acid sequence in a sample.

The present invention relates to a digital method for detecting and/or quantifying at least one target biomolecules in a sample, said biomolecules being selected from DNA, RNA, and proteins based on isothermal amplification. The present invention further relates to different applications of the digital method and to a kit.

The present invention relates to a digital method for detecting and/or quantifying at least one target biomolecules in a sample, said biomolecules being selected from DNA, RNA, and proteins based on isothermal amplification. The present invention further relates to different applications of the digital method and to a kit.

This disclosure provides methods and materials for determining whether a particular nucleic acid sequence is present in a test sample. Nucleic acid in the sample is treated with a nuclease mixture that generates monoribonucleotides if the target sequence is present. An exemplary nuclease mixture is a CRISPR associated protein that has endonuclease collateral activity (such as Cas12a), in combination with a guide RNA complementary to the target sequence, a reporter oligonucleotide, and an exonuclease. Upon binding of the Cas/gRNA complex to the target sequence in the sample, the endonuclease activity of the Cas protein cleaves the reporter oligonucleotide internally, rendering it suitable for digestion by the exonuclease. Monoribonucleotides that are generated as a consequence are measured by a bioluminescence detection means such as luciferase. The assay method is sufficiently robust, sensitive, and specific for use with a variety of biological test samples, sometimes without amplification.

This disclosure provides methods and materials for determining whether a particular nucleic acid sequence is present in a test sample. Nucleic acid in the sample is treated with a nuclease mixture that generates monoribonucleotides if the target sequence is present. An exemplary nuclease mixture is a CRISPR associated protein that has endonuclease collateral activity (such as Cas12a), in combination with a guide RNA complementary to the target sequence, a reporter oligonucleotide, and an exonuclease. Upon binding of the Cas/gRNA complex to the target sequence in the sample, the endonuclease activity of the Cas protein cleaves the reporter oligonucleotide internally, rendering it suitable for digestion by the exonuclease. Monoribonucleotides that are generated as a consequence are measured by a bioluminescence detection means such as luciferase. The assay method is sufficiently robust, sensitive, and specific for use with a variety of biological test samples, sometimes without amplification.

Provided herein is a nucleotide cassette comprising an inducible promoter, a nucleotide sequence that corresponds to at least one single stranded RNA diagnostic target, a nucleotide sequence that encodes artemin, a molecular switch and a nucleotide sequence that encodes a DNAse enzyme and is under control of the molecular switch, wherein the single stranded RNA diagnostic target is a sequence detected by a molecular diagnostic assay. In some embodiments the nucleotide cassette can be used to obtain an RNA expression product. Also provided are vectors and cells comprising the nucleotide cassette or the RNA expression product thereof. The nucleotide cassette can further be used to obtain a diagnostic control composition comprising a non-pathogenic recombinant bacterium having a modified genetic content comprising the nucleotide cassette and to methods of producing such recombinant bacteria.

Provided herein is a nucleotide cassette comprising an inducible promoter, a nucleotide sequence that corresponds to at least one single stranded RNA diagnostic target, a nucleotide sequence that encodes artemin, a molecular switch and a nucleotide sequence that encodes a DNAse enzyme and is under control of the molecular switch, wherein the single stranded RNA diagnostic target is a sequence detected by a molecular diagnostic assay. In some embodiments the nucleotide cassette can be used to obtain an RNA expression product. Also provided are vectors and cells comprising the nucleotide cassette or the RNA expression product thereof. The nucleotide cassette can further be used to obtain a diagnostic control composition comprising a non-pathogenic recombinant bacterium having a modified genetic content comprising the nucleotide cassette and to methods of producing such recombinant bacteria.

Disclosed is a hybridisation capture method based on the pyrophosphorolysis reaction. According to the present invention, there is provided a method for increasing the ratio of a first nucleic add sequence to second nucleic add sequence in a sample.